John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$267M |
| 2 |
Amazon
AMZN
|
+$243M |
| 3 |
Applied Materials
AMAT
|
+$242M |
| 4 |
Airbnb
ABNB
|
+$221M |
| 5 |
Meta Platforms (Facebook)
META
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$262M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$259M |
| 3 |
Wells Fargo
WFC
|
+$238M |
| 4 |
Broadcom
AVGO
|
+$233M |
| 5 |
Applovin
APP
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.95% |
| 2 | Healthcare | 13.56% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 9.22% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYSE
2976
Myseum.AI Inc
MYSE
$14.1M
| $50.7K | ﹤0.01% |
28,456
-10,783
| -27% | -$18.5K |
|
2977
Intellicheck
IDN
$58M
| $50.2K | ﹤0.01% |
17,921
-12,507
| -41% | -$31.5K |
|
|
AILE
2978
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $49.8K | ﹤0.01% |
118,490
+15,692
| +15% | +$20.1K |
|
|
CLLS
2979
Cellectis
CLLS
$320M
| $49.2K | ﹤0.01% |
27,322
-6,090
| -18% | -$11.4K |
|
2980
InflaRx
IFRX
$304M
| $48.7K | ﹤0.01% |
19,716
-4,297
| -18% | -$8.26K |
|
2981
Duluth Holdings
DLTH
$144M
| $48.2K | ﹤0.01% |
15,593
-17,361
| -53% | -$63.1K |
|
|
CTV
2982
DELISTED
Innovid Corp.
CTV
| $48.1K | ﹤0.01% |
+15,553
| New | +$36.7K |
|
2983
Wrap Technologies
WRAP
$90.8M
| $47.8K | ﹤0.01% |
22,527
-23,733
| -51% | -$39.1K |
|
|
LVTX
2984
DELISTED
LAVA Therapeutics
LVTX
| $46.4K | ﹤0.01% |
48,772
-53,994
| -53% | -$84.8K |
|
|
DHC
2985
Diversified Healthcare Trust
DHC
$1.93B
| $46.3K | ﹤0.01% |
20,116
-181,726
| -90% | -$535K |
|
|
WIMI
2986
WiMi Hologram Cloud
WIMI
$25.6M
| $45.3K | ﹤0.01% |
+2,447
| New | +$23.4K |
|
|
ITRM
2987
DELISTED
Iterum Therapeutics
ITRM
| $44.7K | ﹤0.01% |
+25,245
| New | +$39.6K |
|
|
GLXG
2988
Galaxy Payroll Group
GLXG
$6.32M
| $44.2K | ﹤0.01% |
+4,461
| New | +$279K |
|
|
LYRA
2989
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $43.3K | ﹤0.01% |
4,200
-1,451
| -26% | -$16K |
|
2990
iPower
IPW
$469K
| $43.1K | ﹤0.01% |
24
+15
| +167% | +$39K |
|
2991
908 Devices
MASS
$459M
| $41.8K | ﹤0.01% |
+19,000
| New | +$54.4K |
|
2992
Smith Micro Software
SMSI
$16.5M
| $41.5K | ﹤0.01% |
6,342
+4,064
| +178% | +$18.8K |
|
|
ADAP
2993
DELISTED
Adaptimmune Therapeutics
ADAP
| $41.1K | ﹤0.01% |
76,347
+19,146
| +33% | +$14K |
|
|
BOLD
2994
Boundless Bio
BOLD
$66.9M
| $40K | ﹤0.01% |
13,808
-13,052
| -49% | -$38K |
|
2995
Rafael Holdings
RFL
$113M
| $39.4K | ﹤0.01% |
24,219
-789
| -3% | -$1.48K |
|
|
RVPH
2996
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $38.3K | ﹤0.01% |
1,058
-10
| -0.9% | -$278 |
|
2997
Cognition Therapeutics
CGTX
$94.1M
| $37.7K | ﹤0.01% |
53,691
+42,321
| +372% | +$20.9K |
|
2998
GigaMedia
GIGM
$15.9M
| $37.3K | ﹤0.01% |
24,120
-3
| -0% | -$4 |
|
2999
OmniAb
OABI
$650M
| $36.4K | ﹤0.01% |
10,292
-4,909
| -32% | -$19.4K |
|
3000
Senseonics Holdings Inc
SENS
$499M
| $35.9K | ﹤0.01% |
+3,428
| New | +$24.5K |
|
Similar funds
John Overdeck's Q4 2024 Portfolio in Review
As of Q4 2024, John Overdeck held 3,590 positions worth $45.9B, up 0.48% from $45.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $1.69B in Q4 2024, closing 427 positions and reducing 1,388 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $184M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Intel worth $237M.
- John Overdeck's largest Q4 2024 buy was Intel: 11,843,258 shares worth $237M.
- John Overdeck added most to Amazon in Q4 2024, an estimated $243M increase.
- John Overdeck's biggest Q4 2024 reduction was Micron Technology, cutting an estimated $262M.
- John Overdeck fully exited iShares MSCI Emerging Markets ETF in Q4 2024, selling an estimated $184M.
- John Overdeck's ten largest holdings make up 7.2% of its $45.9B portfolio in Q4 2024.
- John Overdeck opened 477 new positions and closed 427 in Q4 2024.
- John Overdeck's portfolio value rose 0.48% quarter-over-quarter to $45.9B.
Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.